期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

2010年国际腹膜透析学会腹膜透析相关性感染指南解读 被引量：13

Interpretation of guideline for peritoneal dialysis-related infections
原文传递
导出
摘要 腹膜透析(PD)相关性感染是PD主要的并发症,也是患者退出PD的主要原因。各中心需结合自身情况,遵循指南建议对PD相关感染进行个体化治疗。腹膜炎的治疗目的应该是迅速控制感染以及保护腹膜功能,而不是挽救PD导管。 Peritoneal dialysis （ PD ） -related infections, remain a leading complication of PD and the major cause of dropout. In line with its own conditions, every PD center should follow the guideline to carry out individualized treatment. Peritonitis treatment should aim at rapid resolution of inflammation and preservation of peritoneal membrane function, but not at saving the peritoneal catheter.
作者 李德天 张蓓茹
机构地区 中国医科大学附属盛京医院肾内科
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2013年第6期445-447,共3页 Chinese Journal of Practical Internal Medicine
关键词 腹膜透析 腹膜透析相关性感染 腹膜炎 peritoneal dialysis peritoneal dialysis-related infections peritonitis
分类号 R459.5 [医药卫生—治疗学]
  • 相关文献

参考文献8

  • 1钱家麒.腹膜透析在终末期肾衰竭一体化治疗中的作用[J].中国实用内科杂志,2010,30(12):1160-1162. 被引量：12
  • 2Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infec- tions recommendations: 2010 update [ J ]. Petit Dial Int, 2010,30 (4) :393 -423.
  • 3Kwan TH,Tong MK, Siu YP, et al. Uhrasonography in the manage- ment of exit site infections in peritoneal dialysis patients [ J ]. Neph- rology(Carlton) ,2004,9(6) :348 -352.
  • 4Baker R J, Senior H, Clemenger M, et al. Empirical aminoglycosides for peritonitis do not affect residual" renal function[J].Am J Kidney Dis ,2003,41 ( 3 ) :670 - 675.
  • 5Szeto CC, Chow KW, Kwan BC, et al. Staphylococcus aureus perito- nitis complicates peritoneal dialysis:review of 245 consecutive cases [J]. Clin J Am Soc Nephrol,2007,2(2) :245 -251.
  • 6Siva B, Hawley CM, McDonald SP, et al. Pseudomonas peritonitis in Australia : predictors, treatment, and outcomes in 191 cases [ J ]. Clin J Am Soc Nephro1,2009,4 ( 5 ) :957 - 964.
  • 7Miles R, Hawley CM, McDonald SP, et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients [ J]. Kidney Int, 2009,76(6) :622 -628.
  • 8Restrepo C, Chacon J, Manjarres G. Fungal peritonitis in peritoneal dialysis patients:successful prophylaxis with fluconasole, as demon- strated by prospective randomized control trial [ J ]. Petit Dial Int, 2010,30(6) :619 -625.

二级参考文献10

  • 1Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infec- tions recommendations : 2010 Update [ J ]. Perit Dial In, 2010,4 : 393 - 423.
  • 2Figueiredo A, Gob BL, Jenkins S, et al. Clinical Practice Guide- lines for Peritoneal Access [ J ]. Perit Dial Int, 2010,4:424 - 429.
  • 3Covic A, Bammens B, Lobbedez T. Educating end-stage renal dis- ease patients on dialysis modality selection:clinical advice from the European Renal Best Practice (ERBP)Advisory Board [ J ]. Neph- rol Dial Transplant ,2010,25 : 1757 - 1759.
  • 4National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for 2006 updates:hemodial- ysis adequacy, peritoneal dialysis adequacy and vascular Access [ J ]. Am J Kidney Dis,2006,48 : S1 - S322.
  • 5Kendrick J, Teitelbaum I. Strategies for improving long-term sur- vival in peritoneal dialysis patients [ J ]. Clin J Am Soc Nephrol, 2010,5:1123 - 1131.
  • 6Sarnak MJ,Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardi- ovascular Disease, High Blood Pressure Research, Clinical Cardiol- ogy, and Epidemiology and Prevention [ J ]. Hypertension, 2003, 42 : 1050 - 1065.
  • 7Sesso R, Belasco AG. Late diagnosis of chronic renal failure and mortality on maintenance dialysis [ J ]. Nephro Dial Transplant, 1996,11:2417 - 2420.
  • 8Fenton SS, Schaubel DE, Desmeules M, et al. Hemodialysis versus peritoneal dialysis : a comparison of adjusted mortality rates [ J ]. Am J Kidney Dis, 1997,30 ( 3 ) :334 - 342.
  • 9US Renal Data System USRDS 2008 Annum Data Report, National Institutes of Health. National institutes of diabetes and digestive and kidney diseases [ R ]. Bethesda ,2008.
  • 10Li PK, Szeto CC. Success of the peritoneal dialysis programme in Hong Kong[ J]. Nephrol Dial Transplant,2008,23:1475 - 1478.

共引文献11

同被引文献94

  • 1曾秀燕,鲁梅玉.注射用盐酸头孢替安所致不良反应的特点及规律分析[J].求医问药（下半月）,2013(10):320-321. 被引量：5
  • 2倪军,童孟立,崔杏成.72例次持续性非卧床腹透腹膜炎分析[J].中国中西医结合肾病杂志,2007,8(4):217-219. 被引量：24
  • 3陈香美.腹膜透析标准操作规程[M].北京:人民军医出版社,2011:101.
  • 4Zelenitsky S, Barns L, Findlay I, et al. Analysis of microbiological trends in peritoneal dialysis-r elated peritonitis from 1991 to 1998 [ J]. AM J Kidney Dis,2000,36 : 1009 - 1013.
  • 5Krishnan M, Thodis E, Ikonomopoulos D, et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis [ J ]. Perit Dial 1nt,2002,22:573 - 581.
  • 6Singha) MK,Vas Sl.Oreopoulos DG’et al .Trea1;men1; of peritoneal dialysiscatheter - related infectious by simultaneous catheter removal andreplacement.Is it safe[J]. Perit Dial int, I 998,1 8(6) ; 565-567.
  • 7Bailie GR, Eisele G. Continuous ambulatory peritoneal dialy- sis: a review of its mechanics, advantages, complications, and areas of controversy[J]. Ann Pharmacother, 1992, 26 (4), 1409-1420.
  • 8Steinberg SM, Cutler SJ, Nolph KD, et al. A comprehensive report on the experience of patients on continuous ambulatory peritoneal dialysis for the treatment of end-stage renal disease [J]. Am J Kidney Dis, 1984, ,4(3) : 233 241.
  • 9Yimazlar T, Yavuz M, Ceylan H. Laparoscopic management of malfunction peritoneal dialysis eatheters[J]. Surg Endosc, 2001, 15(8): 820-822.
  • 10Piraino B, Bailie GR, Bemaldini J, et al. Peritoneal dialysis- related infections recommendations:2005 update[J].Perit Dial Int, 2005, 25(2).. 107-131.

引证文献13

二级引证文献52

中国实用内科杂志
2013年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部